Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss

PLoS ONE - United States
doi 10.1371/journal.pone.0005647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Loss of DNAM-1 Contributes to CD8+T-cell Exhaustion in Chronic HIV-1 Infection

European Journal of Immunology
AllergyImmunology
2010English

Effect of Lamivudine in HIV-Infected Persons With Prior Exposure to Zidovudine/Didanosine or Zidovudine/Zalcitabine

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2000English

Post-Exposure Prophylaxis for HIV Infection: A Clinical Trial Comparing Lopinavir/Ritonavir Versus Atazanavir Each With Zidovudine/Lamivudine

Antiviral Therapy
Infectious DiseasesPharmacology
2011English

Studies on HIV Resistance to Multiple Drug Therapy (Lamivudine, Zidovudine and Nevirapine) in Benin Metropolis, Nigeria

International Journal of Scientific Research in Environmental Science and Toxicology
2016English

Pharmacological Basis for Concentration-Controlled Therapy With Zidovudine, Lamivudine, and Indinavir

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

New England Journal of Medicine
Medicine
2009English

Zidovudine After Occupational Exposure to HIV

BMJ
1991English

The Triple Combination Indinavir-Zidovudine-Lamivudine Is Highly Synergistic

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Treatment With Indinavir, Zidovudine, and Lamivudine in Adults With Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

New England Journal of Medicine
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy